Cipla Limited
CIPLA
Κατάταξη σε μετοχές
#1819
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Τιμή μετοχής
$14.61
Κεφαλαιοποίηση
$11.80B
Αλλαγή (1 ημέρα)
-0.12%
Αλλαγή (1 έτος)
-18.47%
Χώρα
IN
Εμπόριο Cipla Limited (CIPLA)
Κατηγορία
Healthcare
Ιστορικό μερισμάτων για Cipla Limited (CIPLA)
Η μετοχή Cipla Limited (σύμβολο: CIPLA) κατέβαλε συνολικά 30 μερίσματα.
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $87.50
Απόδοση μερίσματος (TTM): 0.0098
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $87.50
Απόδοση μερίσματος (TTM): 0.0098
Καταβολές μερισμάτων για Cipla Limited (CIPLA) από 1997 έως 2026
Ετήσιες καταβολές μερισμάτων
| Έτος | Μέρισμα (προσαρμοσμένο για διασπάσεις μετοχών) | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $16.00 | 0.00% |
| 2025 | $16.00 | 23.08% |
| 2024 | $13.00 | 52.94% |
| 2023 | $8.50 | 70.00% |
| 2022 | $5.00 | 0.00% |
| 2021 | $5.00 | 25.00% |
| 2020 | $4.00 | 33.33% |
| 2019 | $3.00 | 0.00% |
| 2018 | $3.00 | 50.00% |
| 2017 | $2.00 | 0.00% |
| 2016 | $2.00 | 0.00% |
| 2015 | $2.00 | 0.00% |
| 2014 | $2.00 | 0.00% |
| 2013 | $2.00 | 0.00% |
| 2012 | $2.00 | 0.00% |
| 2011 | $2.00 | -28.57% |
| 2010 | $2.80 | 40.00% |
| 2009 | $2.00 | 0.00% |
| 2008 | $2.00 | 0.00% |
| 2007 | $2.00 | 0.00% |
| 2006 | $2.00 | 42.86% |
| 2005 | $1.40 | 16.67% |
| 2004 | $1.20 | 50.00% |
| 2003 | $0.8 | 42.86% |
| 2002 | $0.56 | 55.56% |
| 2001 | $0.36 | -18.18% |
| 2000 | $0.44 | 120.00% |
| 1999 | $0.2 | 36.33% |
| 1998 | $0.1467 | 57.23% |
| 1997 | $0.0933 | 0.00% |
Λίστα όλων των καταβολών μερισμάτων
| Έτος | Μέρισμα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $16.00 | 0.00% |
| 2025 | $16.00 | 23.08% |
| 2024 | $13.00 | 52.94% |
| 2023 | $8.50 | 70.00% |
| 2022 | $5.00 | 0.00% |
| 2021 | $5.00 | 25.00% |
| 2020 | $4.00 | 33.33% |
| 2019 | $3.00 | 0.00% |
| 2018 | $3.00 | 50.00% |
| 2017 | $2.00 | 0.00% |
| 2016 | $2.00 | 0.00% |
| 2015 | $2.00 | 0.00% |
| 2014 | $2.00 | 0.00% |
| 2013 | $2.00 | 0.00% |
| 2012 | $2.00 | 0.00% |
| 2011 | $2.00 | -28.57% |
| 2010 | $2.80 | 40.00% |
| 2009 | $2.00 | 0.00% |
| 2008 | $2.00 | 0.00% |
| 2007 | $2.00 | 0.00% |
| 2006 | $2.00 | -42.86% |
| 2005 | $3.50 | 16.67% |
| 2004 | $3.00 | -70.00% |
| 2003 | $10.00 | 42.86% |
| 2002 | $7.00 | 55.56% |
| 2001 | $4.50 | -18.18% |
| 2000 | $5.50 | -75.56% |
| 1999 | $22.50 | 36.36% |
| 1998 | $16.50 | 57.14% |
| 1997 | $10.50 | 0.00% |
Καταβολές μερισμάτων για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Αριθμός καταβολών μερισμάτων | Χώρα |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
